Systemic Inflammation Induces Acute Behavioral and Cognitive Changes and Accelerates Neurodegenerative Disease

Biological Psychiatry

Volumn 65, Issue 4, 2009, Pages 304-312

  Cunningham, Colm ^a   Campion, Suzanne ^b   Lunnon, Katie ^b   Murray, Carol L ^a   Woods, Jack F C ^a   Deacon, Robert M J ^c   Rawlins, J Nicholas P ^c   Perry, V Hugh ^b  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Alzheimer's disease; cytokines; delirium; inflammation; microglial priming; neurodegeneration; systemic

Indexed keywords

BETA INTERFERON; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COGNITION; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HYPOTHERMIA; LOCOMOTION; MOTOR COORDINATION; MOUSE; NERVE DEGENERATION; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL;

ANIMALS; BEHAVIOR, ANIMAL; BODY TEMPERATURE; COGNITION; FEMALE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INFUSIONS, PARENTERAL; LIPOPOLYSACCHARIDES; LONGITUDINAL STUDIES; MAZE LEARNING; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; NEURODEGENERATIVE DISEASES; PSYCHOMOTOR PERFORMANCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 58349119112     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2008.07.024     Document Type: Article

References (52)

1. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M., et al. Inflammation and Alzheimer's disease. Neurobiol Aging 21 (2000) 383-421
2. Etminan M., Gill S., and Samii A. Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: Systematic review and meta-analysis of observational studies. BMJ 327 (2003) 128
3. Aisen P.S. The potential of anti-inflammatory drugs for the treatment of Alzheimer's disease. Lancet Neurol 1 (2002) 279-284
4. Firuzi O., and Pratico D. Coxibs and Alzheimer's disease: Should they stay or should they go?. Ann Neurol 59 (2006) 219-228
5. McGeer P.L., and McGeer E.G. NSAIDs and Alzheimer disease: Epidemiological, animal model and clinical studies. Neurobiol Aging 28 (2007) 639-647
6. Lerner A.J., Hedera P., Koss E., Stuckey J., and Friedland R.P. Delirium in Alzheimer disease. Alzheimer Dis Assoc Disord 11 (1997) 16-20
7. George J., Bleasdale S., and Singleton S.J. Causes and prognosis of delirium in elderly patients admitted to a district general hospital. Age Ageing 26 (1997) 423-427
8. Rahkonen T., Makela H., Paanila S., Halonen P., Sivenius J., and Sulkava R. Delirium in elderly people without severe predisposing disorders: Etiology and 1-year prognosis after discharge. Int Psychogeriatr 12 (2000) 473-481
9. Murray A.M., Levkoff S.E., Wetle T.T., Beckett L., Cleary P.D., Schor J.D., et al. Acute delirium and functional decline in the hospitalized elderly patient. J Gerontol 48 (1993) M181-M186
10. Rockwood K., Cosway S., Carver D., Jarrett P., Stadnyk K., and Fisk J. The risk of dementia and death after delirium. Age Ageing 28 (1999) 551-556
11. Pitkala K.H., Laurila J.V., Strandberg T.E., and Tilvis R.S. Prognostic significance of delirium in frail older people. Dement Geriatr Cogn Disord 19 (2005) 158-163
12. Dantzer R. Cytokine-induced sickness behaviour: A neuroimmune response to activation of innate immunity. Eur J Pharmacol 500 (2004) 399-411
13. Combrinck M.I., Perry V.H., and Cunningham C. Peripheral infection evokes exaggerated sickness behaviour in pre-clinical murine prion disease. Neuroscience 112 (2002) 7-11
14. Betmouni S., Perry V.H., and Gordon J.L. Evidence for an early inflammatory response in the central nervous system of mice with scrapie. Neuroscience 74 (1996) 1-5
15. Cunningham C., Boche D., and Perry V.H. Transforming growth factor beta1, the dominant cytokine in murine prion disease: Influence on inflammatory cytokine synthesis and alteration of vascular extracellular matrix. Neuropathol Appl Neurobiol 28 (2002) 107-119
16. Cunningham C., Wilcockson D.C., Boche D., and Perry V.H. Comparison of inflammatory and acute-phase responses in the brain and peripheral organs of the ME7 model of prion disease. J Virol 79 (2005) 5174-5184
17. Walsh D.T., Betmouni S., and Perry V.H. Absence of detectable IL-1beta production in murine prion disease: A model of chronic neurodegeneration. J Neuropathol Exp Neurol 60 (2001) 173-182
18. Cunningham C., Wilcockson D.C., Campion S., Lunnon K., and Perry V.H. Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration. J Neurosci 25 (2005) 9275-9284
19. Deacon R.M., Bannerman D.M., Kirby B.P., Croucher A., and Rawlins J.N. Effects of cytotoxic hippocampal lesions in mice on a cognitive test battery. Behav Brain Res 133 (2002) 57-68
20. Deacon R.M. Burrowing in rodents: A sensitive method for detecting behavioral dysfunction. Nat Protoc 1 (2006) 118-121
21. Felton L.M., Cunningham C., Rankine E.L., Waters S., Boche D., and Perry V.H. MCP-1 and murine prion disease: Separation of early behavioural dysfunction from overt clinical disease. Neurobiol Dis 20 (2005) 283-295
22. Deacon R.M., Cholerton L.L., Talbot K., Nair-Roberts R.G., Sanderson D.J., Romberg C., et al. Age-dependent and -independent behavioral deficits in Tg2576 mice. Behav Brain Res 189 (2008) 126-138
23. Deacon R.M., and Rawlins J.N. Learning impairments of hippocampal-lesioned mice in a paddling pool. Behav Neurosci 116 (2002) 472-478
24. Reisel D., Bannerman D.M., Schmitt W.B., Deacon R.M., Flint J., Borchardt T., et al. Spatial memory dissociations in mice lacking GluR1. Nat Neurosci 5 (2002) 868-873
25. Kondziela W. A new method for the measurement of muscle relaxation in white mice [in German]. Arch Int Pharmacodyn Ther 152 (1964) 277-284
26. Cunningham C., Campion S., Teeling J., Felton L., and Perry V.H. The sickness behaviour and CNS inflammatory mediator profile induced by systemic challenge of mice with synthetic double-stranded RNA (poly I:C). Brain Behav Immun 21 (2007) 490-502
27. Greer G.G., and Rietschel E.T. Lipid A-induced tolerance and hyperreactivity to hypothermia in mice. Infect Immun 19 (1978) 357-368
28. Perry V.H., Newman T.A., and Cunningham C. The impact of systemic infection on the progression of neurodegenerative disease. Nat Rev Neurosci 4 (2003) 103-112
29. Frank M.G., Barrientos R.M., Biedenkapp J.C., Rudy J.W., Watkins L.R., and Maier S.F. mRNA up-regulation of MHC II and pivotal pro-inflammatory genes in normal brain aging. Neurobiol Aging 27 (2006) 717-722
30. Perry V.H., Matyszak M.K., and Fearn S. Altered antigen expression of microglia in the aged rodent CNS. Glia 7 (1993) 60-67
31. Guenther K., Deacon R.M., Perry V.H., and Rawlins J.N. Early behavioural changes in scrapie-affected mice and the influence of dapsone. Eur J Neurosci 14 (2001) 401-409
32. Cunningham C., Deacon R., Wells H., Boche D., Waters S., Diniz C.P., et al. Synaptic changes characterize early behavioural signs in the ME7 model of murine prion disease. Eur J Neurosci 17 (2003) 2147-2155
33. Sims J.E., Gayle M.A., Slack J.L., Alderson M.R., Bird T.A., Giri J.G., et al. Interleukin 1 signaling occurs exclusively via the type I receptor. Proc Natl Acad Sci U S A 90 (1993) 6155-6159
34. Sparkman N.L., Kohman R.A., Garcia A.K., and Boehm G.W. Peripheral lipopolysaccharide administration impairs two-way active avoidance conditioning in C57BL/6J mice. Physiol Behav 85 (2005) 278-288
35. Sparkman N.L., Kohman R.A., Scott V.J., and Boehm G.W. Bacterial endotoxin-induced behavioral alterations in two variations of the Morris water maze. Physiol Behav 86 (2005) 244-251
36. Sparkman N.L., Martin L.A., Calvert W.S., and Boehm G.W. Effects of intraperitoneal lipopolysaccharide on Morris maze performance in year-old and 2-month-old female C57BL/6J mice. Behav Brain Res 159 (2005) 145-151
37. Kohman R.A., Tarr A.J., Byler S.L., and Boehm G.W. Age increases vulnerability to bacterial endotoxin-induced behavioral decrements. Physiol Behav 91 (2007) 561-565
38. Barrientos R.M., Higgins E.A., Biedenkapp J.C., Sprunger D.B., Wright-Hardesty K.J., Watkins L.R., et al. Peripheral infection and aging interact to impair hippocampal memory consolidation. Neurobiol Aging 27 (2006) 723-732
39. Chen J., Buchanan J.B., Sparkman N.L., Godbout J.P., Freund G.G., and Johnson R.W. Neuroinflammation and disruption in working memory in aged mice after acute stimulation of the peripheral innate immune system. Brain Behav Immun 22 (2008) 301-311
40. Brown T.M., and Boyle M.F. Delirium. BMJ 325 (2002) 644-647
41. Elie M., Rousseau F., Cole M., Primeau F., McCusker J., and Bellavance F. Prevalence and detection of delirium in elderly emergency department patients. CMAJ 163 (2000) 977-981
42. Fick D.M., Agostini J.V., and Inouye S.K. Delirium superimposed on dementia: A systematic review. J Am Geriatr Soc 50 (2002) 1723-1732
43. Nguyen M.D., D'Aigle T., Gowing G., Julien J.P., and Rivest S. Exacerbation of motor neuron disease by chronic stimulation of innate immunity in a mouse model of amyotrophic lateral sclerosis. J Neurosci 24 (2004) 1340-1349
44. Kitazawa M., Oddo S., Yamasaki T.R., Green K.N., and LaFerla F.M. Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease. J Neurosci 25 (2005) 8843-8853
45. Sly L.M., Krzesicki R.F., Brashler J.R., Buhl A.E., McKinley D.D., Carter D.B., and Chin J.E. Endogenous brain cytokine mRNA and inflammatory responses to lipopolysaccharide are elevated in the Tg2576 transgenic mouse model of Alzheimer's disease. Brain Res Bull 56 (2001) 581-588
46. Brugg B., Dubreuil Y.L., Huber G., Wollman E.E., Delhaye-Bouchaud N., and Mariani J. Inflammatory processes induce beta-amyloid precursor protein changes in mouse brain. Proc Natl Acad Sci U S A 92 (1995) 3032-3035
47. Jackson J.C., Gordon S.M., Hart R.P., Hopkins R.O., and Ely E.W. The association between delirium and cognitive decline: A review of the empirical literature. Neuropsychol Rev 14 (2004) 87-98
48. Holmes C., El-Okl M., Williams A.L., Cunningham C., Wilcockson D., and Perry V.H. Systemic infection, interleukin 1beta, and cognitive decline in Alzheimer's disease. J Neurol Neurosurg Psychiatry 74 (2003) 788-789
49. Chakravarty S., and Herkenham M. Toll-like receptor 4 on nonhematopoietic cells sustains CNS inflammation during endotoxemia, independent of systemic cytokines. J Neurosci 25 (2005) 1788-1796
50. Singh A.K., and Jiang Y. How does peripheral lipopolysaccharide induce gene expression in the brain of rats?. Toxicology 201 (2004) 197-207
51. Godoy M.C., Tarelli R., Ferrari C.C., Sarchi M.I., and Pitossi F.J. Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease. Brain 131 Pt 7 (2008) 1880-1894
52. Teeling J.L., Felton L.M., Deacon R.M., Cunningham C., Rawlins J.N., and Perry V.H. Sub-pyrogenic systemic inflammation impacts on brain and behavior, independent of cytokines. Brain Behav Immun 21 (2007) 836-850